Again normally a biotech own's the IP and if successful, licenses that out to a third party. Here NNVC doesn't own the IP and is the third party licensee that pays to develop the IP. NNVC need's to and should own the IP that it has paid for the development of. Other biotechs own their own IP.
Market Data 
Markets
AI
